AcquisitionOther
Oaktree Acquisition Corp. II acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Oaktree Acquisition Corp. II -> target · $450 million
II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company Alvotech is a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global markets.
Open source record (SEC) ↗